Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
05 May 2025
| Name: | MAYNE PHARMA LIMITED (MYP) |
| Date of Listing: | 21 November 2005 |
| Date of Delisting: | 05 February 2007 |
Stock Exchange Status:
This entity was delisted from the Australian Securities Exchange on 05 February 2007.Legal Status:
To our knowledge this entity was the subject of a takeover or merger such that your securities were acquired for consideration in the form of cash or scrip. We have not therefore verified the current legal status of this entity. If you have questions about your shareholding, as we say elsewhere, they may be taken up here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.Capital Gains Tax (CGT) Status:
To our knowledge this entity was the subject of a takeover or merger such that your securities were acquired for consideration in the form of cash or scrip. You will need to seek independent tax advice in relation to Capital Gains Tax or other tax matters but any other enquiries relating to your shareholding in the company should be followed up via our online form here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
REGISTRY:
Link Market Services Melbourne
Tower 4, 727 Collins Street Docklands VIC 3008
Tel : +61 3 9615 9800 or 61 1300 554 474
Fax : +61 2 9287 0303
RegistryWebsite RegistryEmail
many shareholders in this company have unclaimed money due to them - deListed provides a tracing service for a small administration fee that identifies where people can find unclaimed monies arising from compulsory acquisitions and also from dividend distributions, super contributions, inoperative bank, building society or credit union accounts, bequests and other sources - please click here for access to our Lost shares, Lost money?? service | 31/03/2022 |
delisted at the request of the Company, under listing rule 17.11 | 05/02/2007 |
we understand Hospira was successful with an offer of $4.10 per Mayne Pharma share | 05/02/2007 |
securities suspended from quotation following lodgement of the court orders with ASIC in relation to the scheme of arrangement whereby all the Company's shares will be acquired by Hospira Inc | 22/01/2007 |
we understand that on or about this date the company undertook, proposed to undertake or was the subject of the following corporate action: - Mayne Pharma shareholders will receive $4.10 cash under scheme with Hospira Inc - this corporate event may appear elsewhere in this company record | 22/01/2007 |
Mayne Group Limited (Mayne) undertook a number of transactions to separate the ownership of the international pharmaceutical business (to Mayne Pharma and its subsidiaries) - Mayne (now Symbion Health Limited) retained the domestic healthcare businesses - as a result of the demerger, Mayne shareholders held shares in both Symbion Health and Mayne Pharma - the demerger was undertaken via a Scheme of Arrangement whereby Mayne undertook a capital reduction under which a total of approximately $1.56 billion of contributed capital was returned to Mayne shareholders (capital reduction amount) - this amounted to approximately $2.45 per ordinary issued Mayne share - the capital reduction amount was applied on behalf of Mayne shareholders for the subscription of approximately 636 million new shares in Mayne Pharma - Mayne shareholders subscribed for one new Mayne Pharma share for every one Mayne share they held before the demerger and Mayne Pharma used the funds received on the issue of the new shares to repay outstanding loans to Mayne | 18/11/2005 |
many shareholders in this company have unclaimed money due to them - deListed provides a tracing service for a small administration fee that identifies where people can find unclaimed monies arising from compulsory acquisitions and also from dividend distributions, super contributions, inoperative bank, building society or credit union accounts, bequests and other sources - please click here for access to our Lost shares, Lost money?? service | 31/03/2022 |
delisted at the request of the Company, under listing rule 17.11 | 05/02/2007 |
we understand Hospira was successful with an offer of $4.10 per Mayne Pharma share | 05/02/2007 |
securities suspended from quotation following lodgement of the court orders with ASIC in relation to the scheme of arrangement whereby all the Company's shares will be acquired by Hospira Inc | 22/01/2007 |
we understand that on or about this date the company undertook, proposed to undertake or was the subject of the following corporate action: - Mayne Pharma shareholders will receive $4.10 cash under scheme with Hospira Inc - this corporate event may appear elsewhere in this company record | 22/01/2007 |
Mayne Group Limited (Mayne) undertook a number of transactions to separate the ownership of the international pharmaceutical business (to Mayne Pharma and its subsidiaries) - Mayne (now Symbion Health Limited) retained the domestic healthcare businesses - as a result of the demerger, Mayne shareholders held shares in both Symbion Health and Mayne Pharma - the demerger was undertaken via a Scheme of Arrangement whereby Mayne undertook a capital reduction under which a total of approximately $1.56 billion of contributed capital was returned to Mayne shareholders (capital reduction amount) - this amounted to approximately $2.45 per ordinary issued Mayne share - the capital reduction amount was applied on behalf of Mayne shareholders for the subscription of approximately 636 million new shares in Mayne Pharma - Mayne shareholders subscribed for one new Mayne Pharma share for every one Mayne share they held before the demerger and Mayne Pharma used the funds received on the issue of the new shares to repay outstanding loans to Mayne | 18/11/2005 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NATURE | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|---|
| 06/12/2005 | Nora Scheinkestel | On market | 4,100 | $2.470 | $10,127 |
| 06/12/2005 | John Sime | On market | 10,000 | $2.520 | $25,200 |
| 29/11/2005 | Nora Scheinkestel | On market | 11,746 | $2.690 | $31,597 |
| 08/11/2005 | Stuart James | On market | 93,876 | $5.400 | $506,930 |
| 14/10/2005 | Nora Scheinkestel | On market | 7,590 | $5.250 | $39,848 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Peter Wilcox | Chairman | 04/10/2005 |
| Thierry Soursac | Managing Director, CEO | 18/11/2005 |
| Nora Scheinkestel | Director | 04/10/2005 |
| John Sime | Director | 04/10/2005 |
| Rowan Russell | Director | 04/10/2005 |
| Tamara Joseph | General Counsel, Company Secretary | |
| D.C. Kiriacoulacos | Company Secretary |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Paul McClintock | Chairman | 08/06/2005 | 18/11/2005 |
| Stuart James | Managing Director, CEO | 15/08/2004 | 18/11/2005 |
| James Hall | Non Exec Director | 08/06/2005 | 18/11/2005 |
| Ian Blackburne | Non Exec Director | 01/09/2004 | 18/11/2005 |
| Paul Binfield | Director | 18/11/2005 | 18/11/2005 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2025 Investogain Pty Limited. All rights reserved.
